Drug
Act201
Act201: highest development phase Phase 1, developed by Xiamen Amoytop Biotech Co., Ltd.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Xiamen Amoytop Biotech Co., Ltd.
Trials
| Drug | Phase | Indication |
|---|---|---|
| ACT201 Injection NCT07929805 | Phase 1 | Chronic Hepaititis B |
Latest
No recent events.
Follow Act201 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.